首页 > 最新文献

Critical care explorations最新文献

英文 中文
Critical Data for Critical Care: A Primer on Leveraging Electronic Health Record Data for Research From Society of Critical Care Medicine's Panel on Data Sharing and Harmonization. 重症监护的关键数据:重症医学会数据共享与协调小组关于利用电子健康记录数据进行研究的入门指南。
Q4 Medicine Pub Date : 2024-11-15 eCollection Date: 2024-11-01 DOI: 10.1097/CCE.0000000000001179
Smith F Heavner, Vishakha K Kumar, Wes Anderson, Tamara Al-Hakim, Pam Dasher, Donna Lee Armaignac, Gilles Clermont, J Perren Cobb, Sean Manion, Kenneth E Remy, Karin Reuter-Rice, Melissa Haendel

A growing body of critical care research draws on real-world data from electronic health records (EHRs). The bedside clinician has myriad data sources to aid in clinical decision-making, but the lack of data sharing and harmonization standards leaves much of this data out of reach for multi-institution critical care research. The Society of Critical Care Medicine (SCCM) Discovery Data Science Campaign convened a panel of critical care and data science experts to explore and document unique advantages and opportunities for leveraging EHR data in critical care research. This article reviews and illustrates six organizing topics (data domains and common data elements; data harmonization; data quality; data interoperability and digital infrastructure; data access, sharing, and governance; and ethics and equity) as a data science primer for critical care researchers, laying a foundation for future publications from the SCCM Discovery Data Harmonization and Sharing Guiding Principles Panel.

越来越多的重症监护研究利用来自电子健康记录 (EHR) 的真实世界数据。床旁临床医生有无数的数据源来帮助临床决策,但由于缺乏数据共享和统一标准,这些数据大部分都无法用于多机构重症监护研究。重症医学学会(SCCM)发现数据科学运动召集了一个重症医学和数据科学专家小组,以探索和记录在重症医学研究中利用电子病历数据的独特优势和机遇。本文回顾并阐述了六个组织主题(数据域和通用数据元素;数据协调;数据质量;数据互操作性和数字基础设施;数据访问、共享和管理;以及伦理和公平),作为重症医学研究人员的数据科学入门指南,为 SCCM 发现数据协调和共享指导原则小组未来的出版物奠定了基础。
{"title":"Critical Data for Critical Care: A Primer on Leveraging Electronic Health Record Data for Research From Society of Critical Care Medicine's Panel on Data Sharing and Harmonization.","authors":"Smith F Heavner, Vishakha K Kumar, Wes Anderson, Tamara Al-Hakim, Pam Dasher, Donna Lee Armaignac, Gilles Clermont, J Perren Cobb, Sean Manion, Kenneth E Remy, Karin Reuter-Rice, Melissa Haendel","doi":"10.1097/CCE.0000000000001179","DOIUrl":"10.1097/CCE.0000000000001179","url":null,"abstract":"<p><p>A growing body of critical care research draws on real-world data from electronic health records (EHRs). The bedside clinician has myriad data sources to aid in clinical decision-making, but the lack of data sharing and harmonization standards leaves much of this data out of reach for multi-institution critical care research. The Society of Critical Care Medicine (SCCM) Discovery Data Science Campaign convened a panel of critical care and data science experts to explore and document unique advantages and opportunities for leveraging EHR data in critical care research. This article reviews and illustrates six organizing topics (data domains and common data elements; data harmonization; data quality; data interoperability and digital infrastructure; data access, sharing, and governance; and ethics and equity) as a data science primer for critical care researchers, laying a foundation for future publications from the SCCM Discovery Data Harmonization and Sharing Guiding Principles Panel.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"6 11","pages":"e1179"},"PeriodicalIF":0.0,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11573330/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142669425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Subtype Trajectories in Sepsis Patients Admitted to the ICU: A Secondary Analysis of an Observational Study. 入住重症监护室的败血症患者的临床亚型轨迹:一项观察性研究的二次分析。
Q4 Medicine Pub Date : 2024-11-14 eCollection Date: 2024-11-01 DOI: 10.1097/CCE.0000000000001176
Marleen A Slim, Rombout B E van Amstel, Marcella C A Müller, Olaf L Cremer, Alexander P J Vlaar, Tom van der Poll, W Joost Wiersinga, Christopher W Seymour, Lonneke A van Vught

Objectives: Sepsis is an evolving process and proposed subtypes may change over time. We hypothesized that previously established sepsis subtypes are dynamic, prognostic of outcome, and trajectories are associated with host response alterations.

Design: A secondary analysis of two observational critically ill sepsis cohorts: the Molecular diAgnosis and Risk stratification of Sepsis (MARS) and the Medical Information Mart for Intensive Care-IV (MIMIC-IV).

Setting: ICUs in the Netherlands and United States between 2011-2014 and 2008-2019, respectively.

Participants: Patient admission fulfilling the Sepsis-3 criteria upon ICU admission adjudicated to one of four previously identified subtypes, comprising 2,416 admissions in MARS and 10,745 in MIMIC-IV.

Main outcomes and measures: Subtype stability and the changes per subtype on days 2, 4 and 7 of ICU admission were assessed. Next, the associated between change in clinical subtype and outcome and host response alterations.

Results: In MARS, upon ICU admission, 6% (n = 150) of the patient admissions were α-type, 3% (n = 70) β-type, 55% (n = 1317) γ-type, and 36% (n = 879) δ-type; in MIMIC-IV, this was α = 22% (n = 2398), β = 22% (n = 2365), γ = 31% (n = 3296), and δ = 25% (2686). Overall, prevalence of subtypes was stable over days 2, 4, and 7. However, 28-56% (MARS/MIMIC-IV) changed from α on ICU admission to any of the other subtypes on day 2, 33-71% from β, 57-32% from γ, and 50-48% from δ. On day 4, overall subtype persistence was 33-36%. γ or δ admissions remaining in, or transitioning to, subtype γ on days 2, 4, and 7 exhibited lower mortality rates compared with those remaining in, or transitioning to, subtype δ. Longitudinal host response biomarkers reflecting inflammation, coagulation, and endothelial dysfunction were most altered in the δ-δ group, followed by the γ-δ group, independent of the day or biomarker domain.

Conclusions and relevance: In two large cohorts, subtype change to δ was associated with worse clinical outcome and more aberrant biomarkers reflecting inflammation, coagulation, and endothelial dysfunction. These findings underscore the importance of monitoring sepsis subtypes and their linked host responses for improved prognostication and personalized treatment strategies.

目的:脓毒症是一个不断发展的过程,所提出的亚型可能会随着时间的推移而改变。我们假设,以前确定的败血症亚型是动态的,对预后有影响,其轨迹与宿主反应的改变有关:设计:对两个观察性重症脓毒症队列进行二次分析:脓毒症分子诊断与风险分层(MARS)和重症监护医学信息市场-IV(MIMIC-IV):背景:2011-2014年和2008-2019年期间分别在荷兰和美国的重症监护病房:主要结果和测量指标:亚型的稳定性和每个亚型的变化:主要结果和测量指标:评估了亚型的稳定性以及每个亚型在入住 ICU 第 2、4 和 7 天的变化情况。然后,评估临床亚型变化与预后和宿主反应改变之间的相关性:在 MARS 中,入住 ICU 的患者中有 6%(n = 150)为 α 型,3%(n = 70)为 β 型,55%(n = 1317)为 γ 型,36%(n = 879)为 δ 型;在 MIMIC-IV 中,α = 22%(n = 2398),β = 22%(n = 2365),γ = 31%(n = 3296),δ = 25%(2686)。总体而言,亚型的流行率在第 2、4 和 7 天保持稳定。但是,28-56%(MARS/MIMIC-IV)的患者在入住 ICU 第 2 天从 α 转为其他亚型,33-71% 的患者从 β 转为其他亚型,57-32% 的患者从 γ 转为其他亚型,50-48% 的患者从 δ 转为其他亚型。第 4 天,总体亚型持续率为 33-36%。在第 2、4 和 7 天仍处于或过渡到γ亚型的γ或δ入院者的死亡率低于仍处于或过渡到δ亚型的入院者。反映炎症、凝血和内皮功能障碍的纵向宿主反应生物标志物在δ-δ组的改变最大,其次是γ-δ组,与日期或生物标志物域无关:在两个大型队列中,亚型变为δ与较差的临床预后和更多反映炎症、凝血和内皮功能障碍的异常生物标志物有关。这些发现强调了监测败血症亚型及其相关宿主反应对改善预后和个性化治疗策略的重要性。
{"title":"Clinical Subtype Trajectories in Sepsis Patients Admitted to the ICU: A Secondary Analysis of an Observational Study.","authors":"Marleen A Slim, Rombout B E van Amstel, Marcella C A Müller, Olaf L Cremer, Alexander P J Vlaar, Tom van der Poll, W Joost Wiersinga, Christopher W Seymour, Lonneke A van Vught","doi":"10.1097/CCE.0000000000001176","DOIUrl":"10.1097/CCE.0000000000001176","url":null,"abstract":"<p><strong>Objectives: </strong>Sepsis is an evolving process and proposed subtypes may change over time. We hypothesized that previously established sepsis subtypes are dynamic, prognostic of outcome, and trajectories are associated with host response alterations.</p><p><strong>Design: </strong>A secondary analysis of two observational critically ill sepsis cohorts: the Molecular diAgnosis and Risk stratification of Sepsis (MARS) and the Medical Information Mart for Intensive Care-IV (MIMIC-IV).</p><p><strong>Setting: </strong>ICUs in the Netherlands and United States between 2011-2014 and 2008-2019, respectively.</p><p><strong>Participants: </strong>Patient admission fulfilling the Sepsis-3 criteria upon ICU admission adjudicated to one of four previously identified subtypes, comprising 2,416 admissions in MARS and 10,745 in MIMIC-IV.</p><p><strong>Main outcomes and measures: </strong>Subtype stability and the changes per subtype on days 2, 4 and 7 of ICU admission were assessed. Next, the associated between change in clinical subtype and outcome and host response alterations.</p><p><strong>Results: </strong>In MARS, upon ICU admission, 6% (<i>n</i> = 150) of the patient admissions were α-type, 3% (<i>n</i> = 70) β-type, 55% (<i>n</i> = 1317) γ-type, and 36% (<i>n</i> = 879) δ-type; in MIMIC-IV, this was α = 22% (<i>n</i> = 2398), β = 22% (<i>n</i> = 2365), γ = 31% (<i>n</i> = 3296), and δ = 25% (2686). Overall, prevalence of subtypes was stable over days 2, 4, and 7. However, 28-56% (MARS/MIMIC-IV) changed from α on ICU admission to any of the other subtypes on day 2, 33-71% from β, 57-32% from γ, and 50-48% from δ. On day 4, overall subtype persistence was 33-36%. γ or δ admissions remaining in, or transitioning to, subtype γ on days 2, 4, and 7 exhibited lower mortality rates compared with those remaining in, or transitioning to, subtype δ. Longitudinal host response biomarkers reflecting inflammation, coagulation, and endothelial dysfunction were most altered in the δ-δ group, followed by the γ-δ group, independent of the day or biomarker domain.</p><p><strong>Conclusions and relevance: </strong>In two large cohorts, subtype change to δ was associated with worse clinical outcome and more aberrant biomarkers reflecting inflammation, coagulation, and endothelial dysfunction. These findings underscore the importance of monitoring sepsis subtypes and their linked host responses for improved prognostication and personalized treatment strategies.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"6 11","pages":"e1176"},"PeriodicalIF":0.0,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142650019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Septic Shock Requiring Three Vasopressors: Patient Demographics and Outcomes. 需要使用三种血管加压药的脓毒性休克:患者人口统计学和治疗结果
Q4 Medicine Pub Date : 2024-11-08 eCollection Date: 2024-11-01 DOI: 10.1097/CCE.0000000000001167
Gloria H Kwak, Rajapaksha W M A Madushani, Lasith Adhikari, April Y Yan, Eric S Rosenthal, Kahina Sebbane, Zahia Yanes, David Restrepo, Adrian Wong, Leo A Celi, Emmett A Kistler

Objectives: Septic shock is a common condition necessitating timely management including hemodynamic support with vasopressors. Despite the high prevalence and mortality, there is limited data characterizing patients who require three or more vasopressors. We sought to define the demographics, outcomes, and prognostic determinants associated with septic shock requiring three or more vasopressors.

Design: This is a multicenter retrospective cohort of two ICU databases, Medical Information Mart for Intensive Care IV (MIMIC-IV) and electronic ICU-Clinical Research Database, which include over 400,000 patients admitted to 342 ICUs.

Patients: Inclusion criteria entailed patients who were: 1) age 18 years old and older, 2) admitted to any ICU, 3) administered at least three vasopressors for at least 2 hours at any time during their ICU stay, and 4) identified to have sepsis based on the Sepsis-3 criteria.

Interventions: None.

Measurements and main results: A total of 3447 patients met inclusion criteria. The median age was 67 years, 60.5% were male, and 96.6% had full code orders at the time of the third vasopressor initiation. Septic shock requiring three or more vasopressors was associated with 57.6% in-hospital mortality. Code status changes occurred in 23.9% of patients following initiation of a third vasopressor. Elevated lactate upon ICU admission (odds ratio [95% CI], 2.79 [2.73-2.85]), increased duration of time between ICU admission and third vasopressor initiation (1.78 [1.69-1.87]), increased serum creatinine (1.61 [1.59-1.62]), and age above 60 years (1.47 [1.41-1.54]) were independently associated with an increased risk of mortality based on analysis of the MIMIC-IV database. Non-White race and Richmond Agitation-Sedation Scale scores were not associated with mortality.

Conclusions: Septic shock requiring three vasopressors is associated with exceptionally high mortality. Knowledge of patients at highest risk of mortality in this population may inform management and expectations conveyed in shared decision-making.

目的:脓毒性休克是一种常见病,需要及时治疗,包括使用血管加压药进行血液动力学支持。尽管脓毒性休克的发病率和死亡率都很高,但有关需要使用三种或三种以上血管加压药的患者特征的数据却很有限。我们试图确定与需要使用三种或三种以上血管加压药的脓毒性休克相关的人口统计学、结果和预后决定因素:这是一项多中心回顾性队列研究,研究对象是两个重症监护病房数据库,即重症监护医学信息市场IV(MIMIC-IV)和重症监护病房临床研究电子数据库,其中包括342个重症监护病房收治的40多万名患者:纳入标准包括以下患者1)年龄在 18 岁及以上;2)入住任何重症监护病房;3)在入住重症监护病房期间的任何时间至少使用过 3 种血管加压药 2 小时;4)根据败血症-3 标准确定为败血症患者:无干预措施:共有 3447 名患者符合纳入标准。中位年龄为 67 岁,60.5% 为男性,96.6% 的患者在第三次启动血管加压疗法时拥有完整的代码指令。需要使用三次或三次以上血管加压药的脓毒性休克患者的院内死亡率为 57.6%。23.9%的患者在使用第三种血管加压药后代码状态发生变化。根据对 MIMIC-IV 数据库的分析,ICU 入院时乳酸升高(几率比 [95%CI],2.79 [2.73-2.85])、ICU 入院到开始使用第三种血管加压药之间的持续时间延长(1.78 [1.69-1.87])、血清肌酐升高(1.61 [1.59-1.62])和年龄超过 60 岁(1.47 [1.41-1.54])与死亡风险升高密切相关。非白人种族和里士满躁动镇静量表评分与死亡率无关:结论:需要使用三种血管加压药的脓毒性休克患者死亡率极高。了解这类人群中死亡风险最高的患者可为共同决策中的管理和预期提供参考。
{"title":"Septic Shock Requiring Three Vasopressors: Patient Demographics and Outcomes.","authors":"Gloria H Kwak, Rajapaksha W M A Madushani, Lasith Adhikari, April Y Yan, Eric S Rosenthal, Kahina Sebbane, Zahia Yanes, David Restrepo, Adrian Wong, Leo A Celi, Emmett A Kistler","doi":"10.1097/CCE.0000000000001167","DOIUrl":"10.1097/CCE.0000000000001167","url":null,"abstract":"<p><strong>Objectives: </strong>Septic shock is a common condition necessitating timely management including hemodynamic support with vasopressors. Despite the high prevalence and mortality, there is limited data characterizing patients who require three or more vasopressors. We sought to define the demographics, outcomes, and prognostic determinants associated with septic shock requiring three or more vasopressors.</p><p><strong>Design: </strong>This is a multicenter retrospective cohort of two ICU databases, Medical Information Mart for Intensive Care IV (MIMIC-IV) and electronic ICU-Clinical Research Database, which include over 400,000 patients admitted to 342 ICUs.</p><p><strong>Patients: </strong>Inclusion criteria entailed patients who were: 1) age 18 years old and older, 2) admitted to any ICU, 3) administered at least three vasopressors for at least 2 hours at any time during their ICU stay, and 4) identified to have sepsis based on the Sepsis-3 criteria.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>A total of 3447 patients met inclusion criteria. The median age was 67 years, 60.5% were male, and 96.6% had full code orders at the time of the third vasopressor initiation. Septic shock requiring three or more vasopressors was associated with 57.6% in-hospital mortality. Code status changes occurred in 23.9% of patients following initiation of a third vasopressor. Elevated lactate upon ICU admission (odds ratio [95% CI], 2.79 [2.73-2.85]), increased duration of time between ICU admission and third vasopressor initiation (1.78 [1.69-1.87]), increased serum creatinine (1.61 [1.59-1.62]), and age above 60 years (1.47 [1.41-1.54]) were independently associated with an increased risk of mortality based on analysis of the MIMIC-IV database. Non-White race and Richmond Agitation-Sedation Scale scores were not associated with mortality.</p><p><strong>Conclusions: </strong>Septic shock requiring three vasopressors is associated with exceptionally high mortality. Knowledge of patients at highest risk of mortality in this population may inform management and expectations conveyed in shared decision-making.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"6 11","pages":"e1167"},"PeriodicalIF":0.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Septic Shock Requiring Three Vasopressors: Patient Demographics and Outcomes. 需要使用三种血管加压药的脓毒性休克:患者人口统计学和治疗结果
Q4 Medicine Pub Date : 2024-11-08 eCollection Date: 2024-11-01 DOI: 10.1097/CCE.0000000000001167
Gloria H Kwak, Rajapaksha W M A Madushani, Lasith Adhikari, April Y Yan, Eric S Rosenthal, Kahina Sebbane, Zahia Yanes, David Restrepo, Adrian Wong, Leo A Celi, Emmett A Kistler

Objectives: Septic shock is a common condition necessitating timely management including hemodynamic support with vasopressors. Despite the high prevalence and mortality, there is limited data characterizing patients who require three or more vasopressors. We sought to define the demographics, outcomes, and prognostic determinants associated with septic shock requiring three or more vasopressors.

Design: This is a multicenter retrospective cohort of two ICU databases, Medical Information Mart for Intensive Care IV (MIMIC-IV) and electronic ICU-Clinical Research Database, which include over 400,000 patients admitted to 342 ICUs.

Patients: Inclusion criteria entailed patients who were: 1) age 18 years old and older, 2) admitted to any ICU, 3) administered at least three vasopressors for at least 2 hours at any time during their ICU stay, and 4) identified to have sepsis based on the Sepsis-3 criteria.

Interventions: None.

Measurements and main results: A total of 3447 patients met inclusion criteria. The median age was 67 years, 60.5% were male, and 96.6% had full code orders at the time of the third vasopressor initiation. Septic shock requiring three or more vasopressors was associated with 57.6% in-hospital mortality. Code status changes occurred in 23.9% of patients following initiation of a third vasopressor. Elevated lactate upon ICU admission (odds ratio [95% CI], 2.79 [2.73-2.85]), increased duration of time between ICU admission and third vasopressor initiation (1.78 [1.69-1.87]), increased serum creatinine (1.61 [1.59-1.62]), and age above 60 years (1.47 [1.41-1.54]) were independently associated with an increased risk of mortality based on analysis of the MIMIC-IV database. Non-White race and Richmond Agitation-Sedation Scale scores were not associated with mortality.

Conclusions: Septic shock requiring three vasopressors is associated with exceptionally high mortality. Knowledge of patients at highest risk of mortality in this population may inform management and expectations conveyed in shared decision-making.

目的:脓毒性休克是一种常见病,需要及时治疗,包括使用血管加压药进行血液动力学支持。尽管脓毒性休克的发病率和死亡率都很高,但有关需要使用三种或三种以上血管加压药的患者特征的数据却很有限。我们试图确定与需要使用三种或三种以上血管加压药的脓毒性休克相关的人口统计学、结果和预后决定因素:这是一项多中心回顾性队列研究,研究对象是两个重症监护病房数据库,即重症监护医学信息市场IV(MIMIC-IV)和重症监护病房临床研究电子数据库,其中包括342个重症监护病房收治的40多万名患者:纳入标准包括以下患者1)年龄在 18 岁及以上;2)入住任何重症监护病房;3)在入住重症监护病房期间的任何时间至少使用过 3 种血管加压药 2 小时;4)根据败血症-3 标准确定为败血症患者:无干预措施:共有 3447 名患者符合纳入标准。中位年龄为 67 岁,60.5% 为男性,96.6% 的患者在第三次使用血管加压素时拥有完整的代码指令。需要使用三次或三次以上血管加压药的脓毒性休克患者的院内死亡率为 57.6%。23.9%的患者在使用第三种血管加压药后代码状态发生变化。根据对 MIMIC-IV 数据库的分析,ICU 入院时乳酸升高(几率比 [95%CI],2.79 [2.73-2.85])、ICU 入院到开始使用第三种血管加压药之间的持续时间延长(1.78 [1.69-1.87])、血清肌酐升高(1.61 [1.59-1.62])和年龄超过 60 岁(1.47 [1.41-1.54])与死亡风险升高密切相关。非白人种族和里士满躁动镇静量表评分与死亡率无关:结论:需要使用三种血管加压药的脓毒性休克患者死亡率极高。了解这类人群中死亡风险最高的患者可为共同决策中的管理和预期提供参考。
{"title":"Septic Shock Requiring Three Vasopressors: Patient Demographics and Outcomes.","authors":"Gloria H Kwak, Rajapaksha W M A Madushani, Lasith Adhikari, April Y Yan, Eric S Rosenthal, Kahina Sebbane, Zahia Yanes, David Restrepo, Adrian Wong, Leo A Celi, Emmett A Kistler","doi":"10.1097/CCE.0000000000001167","DOIUrl":"https://doi.org/10.1097/CCE.0000000000001167","url":null,"abstract":"<p><strong>Objectives: </strong>Septic shock is a common condition necessitating timely management including hemodynamic support with vasopressors. Despite the high prevalence and mortality, there is limited data characterizing patients who require three or more vasopressors. We sought to define the demographics, outcomes, and prognostic determinants associated with septic shock requiring three or more vasopressors.</p><p><strong>Design: </strong>This is a multicenter retrospective cohort of two ICU databases, Medical Information Mart for Intensive Care IV (MIMIC-IV) and electronic ICU-Clinical Research Database, which include over 400,000 patients admitted to 342 ICUs.</p><p><strong>Patients: </strong>Inclusion criteria entailed patients who were: 1) age 18 years old and older, 2) admitted to any ICU, 3) administered at least three vasopressors for at least 2 hours at any time during their ICU stay, and 4) identified to have sepsis based on the Sepsis-3 criteria.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>A total of 3447 patients met inclusion criteria. The median age was 67 years, 60.5% were male, and 96.6% had full code orders at the time of the third vasopressor initiation. Septic shock requiring three or more vasopressors was associated with 57.6% in-hospital mortality. Code status changes occurred in 23.9% of patients following initiation of a third vasopressor. Elevated lactate upon ICU admission (odds ratio [95% CI], 2.79 [2.73-2.85]), increased duration of time between ICU admission and third vasopressor initiation (1.78 [1.69-1.87]), increased serum creatinine (1.61 [1.59-1.62]), and age above 60 years (1.47 [1.41-1.54]) were independently associated with an increased risk of mortality based on analysis of the MIMIC-IV database. Non-White race and Richmond Agitation-Sedation Scale scores were not associated with mortality.</p><p><strong>Conclusions: </strong>Septic shock requiring three vasopressors is associated with exceptionally high mortality. Knowledge of patients at highest risk of mortality in this population may inform management and expectations conveyed in shared decision-making.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"6 11","pages":"e1167"},"PeriodicalIF":0.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11554353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142633866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heterogeneous Treatment Effects of High-Frequency Oscillatory Ventilation for Acute Respiratory Distress Syndrome: A Post Hoc Analysis of the Oscillation for Acute Respiratory Distress Syndrome Treated Early (OSCILLATE) Trial. 高频振荡通气治疗急性呼吸窘迫综合征的异质性治疗效果:急性呼吸窘迫综合征振荡早期治疗(OSCILLATE)试验的事后分析》。
Q4 Medicine Pub Date : 2024-11-07 eCollection Date: 2024-11-01 DOI: 10.1097/CCE.0000000000001178
Hirotada Kobayashi, Federico Angriman, Niall D Ferguson, Neill K J Adhikari

Objectives: We sought to evaluate whether different subgroups of adults with acute respiratory distress syndrome (ARDS) respond differently to high-frequency oscillatory ventilation (HFOV).

Design: The Oscillation for ARDS Treated Early (OSCILLATE) trial was a randomized controlled trial of HFOV vs. conventional ventilation that found an increased risk of in-hospital mortality (primary outcome) with HFOV. In a post hoc analysis, we applied three different approaches to evaluate heterogeneity of treatment effect for in-hospital mortality: 1) subgroup analyses based on baseline Pao2:Fio2 ratio and oxygenation index (OI); 2) a risk-based approach using a multivariable outcome prediction model; and 3) a clustering approach via multivariable latent class analysis. We used multivariable logistic regression models to assess for interaction.

Setting: Thirty-nine ICUs, five countries.

Subjects: Five hundred forty-eight adults with moderate to severe ARDS.

Interventions: HFOV vs. conventional mechanical ventilation with low tidal volume and higher positive end-expiratory pressure.

Measurements and main results: The effect of HFOV on in-hospital mortality was consistent across categories of Pao2:Fio2 ratio (adjusted odds ratio [aOR], 2.04; 95% CI, 1.32-3.17 and aOR, 1.16; 95% CI, 0.49-2.75 for groups with Pao2:Fio2 above or equal to 80, vs. below 80, respectively; interaction p = 0.23) and OI (aOR, 1.78; 95% CI, 0.67-4.70; aOR, 3.19; 95% CI, 1.44-7.09; aOR, 1.73; 95% CI, 0.82-3.65; and aOR, 1.33; 95% CI, 0.61-2.90 for quartiles of baseline OI, respectively; interaction p = 0.44). Point estimates for the effect of HFOV were consistent across risk categories (aOR, 2.44; 95% CI, 0.40-14.83; aOR, 1.69; 95% CI, 0.75-3.85; and aOR, 2.10; 95% CI, 0.59-7.54 for the lowest, moderate, and highest risk categories, respectively; interaction p = 0.32). Using a clustering approach, point estimates for HFOV were also consistent (cluster 1: aOR, 1.85; 95% CI, 1.15-3.00 and cluster 2: aOR, 1.75; 95% CI, 0.91-3.38; interaction p = 0.75).

Conclusions: We did not identify heterogeneity in the effect of HFOV across different subgroups of patients with ARDS.

研究目的我们试图评估急性呼吸窘迫综合征(ARDS)成人患者的不同亚群是否对高频振荡通气(HFOV)有不同的反应:高频振荡通气与传统通气的随机对照试验发现,高频振荡通气会增加院内死亡风险(主要结果)。在一项事后分析中,我们采用了三种不同的方法来评估院内死亡率治疗效果的异质性:1)基于基线 Pao2:Fio2 比率和氧合指数 (OI) 的亚组分析;2)使用多变量结果预测模型的基于风险的方法;3)通过多变量潜类分析的聚类方法。我们使用多变量逻辑回归模型来评估交互作用:五个国家的 39 个重症监护病房:干预措施:干预措施:HFOV与传统的低潮气量、高呼气末正压机械通气:HFOV对院内死亡率的影响在Pao2:Fio2比率的不同类别中是一致的(Pao2:Fio2高于或等于80的组别与Pao2:Fio2低于80的组别的调整赔率比[aOR]分别为2.04;95% CI,1.32-3.17和aOR,1.16;95% CI,0.49-2.75;交互作用P=0.05)。分别为 1.78;95% CI,0.67-4.70;aOR,3.19;95% CI,1.44-7.09;aOR,1.73;95% CI,0.82-3.65;基线 OI 四分位数分别为 aOR,1.33;95% CI,0.61-2.90;交互作用 p = 0.44)。不同风险类别的 HFOV 效果点估计值一致(最低、中度和最高风险类别分别为 aOR,2.44;95% CI,0.40-14.83;aOR,1.69;95% CI,0.75-3.85;aOR,2.10;95% CI,0.59-7.54;交互作用 p = 0.32)。采用聚类方法,HFOV 的点估计值也是一致的(聚类 1:aOR,1.85;95% CI,1.15-3.00;聚类 2:aOR,1.75;95% CI,0.91-3.38;交互作用 p = 0.75):我们没有发现 HFOV 对不同亚组 ARDS 患者的影响存在异质性。
{"title":"Heterogeneous Treatment Effects of High-Frequency Oscillatory Ventilation for Acute Respiratory Distress Syndrome: A Post Hoc Analysis of the Oscillation for Acute Respiratory Distress Syndrome Treated Early (OSCILLATE) Trial.","authors":"Hirotada Kobayashi, Federico Angriman, Niall D Ferguson, Neill K J Adhikari","doi":"10.1097/CCE.0000000000001178","DOIUrl":"https://doi.org/10.1097/CCE.0000000000001178","url":null,"abstract":"<p><strong>Objectives: </strong>We sought to evaluate whether different subgroups of adults with acute respiratory distress syndrome (ARDS) respond differently to high-frequency oscillatory ventilation (HFOV).</p><p><strong>Design: </strong>The Oscillation for ARDS Treated Early (OSCILLATE) trial was a randomized controlled trial of HFOV vs. conventional ventilation that found an increased risk of in-hospital mortality (primary outcome) with HFOV. In a post hoc analysis, we applied three different approaches to evaluate heterogeneity of treatment effect for in-hospital mortality: 1) subgroup analyses based on baseline Pao<sub>2</sub>:Fio<sub>2</sub> ratio and oxygenation index (OI); 2) a risk-based approach using a multivariable outcome prediction model; and 3) a clustering approach via multivariable latent class analysis. We used multivariable logistic regression models to assess for interaction.</p><p><strong>Setting: </strong>Thirty-nine ICUs, five countries.</p><p><strong>Subjects: </strong>Five hundred forty-eight adults with moderate to severe ARDS.</p><p><strong>Interventions: </strong>HFOV vs. conventional mechanical ventilation with low tidal volume and higher positive end-expiratory pressure.</p><p><strong>Measurements and main results: </strong>The effect of HFOV on in-hospital mortality was consistent across categories of Pao<sub>2</sub>:Fio<sub>2</sub> ratio (adjusted odds ratio [aOR], 2.04; 95% CI, 1.32-3.17 and aOR, 1.16; 95% CI, 0.49-2.75 for groups with Pao<sub>2</sub>:Fio<sub>2</sub> above or equal to 80, vs. below 80, respectively; interaction <i>p</i> = 0.23) and OI (aOR, 1.78; 95% CI, 0.67-4.70; aOR, 3.19; 95% CI, 1.44-7.09; aOR, 1.73; 95% CI, 0.82-3.65; and aOR, 1.33; 95% CI, 0.61-2.90 for quartiles of baseline OI, respectively; interaction <i>p</i> = 0.44). Point estimates for the effect of HFOV were consistent across risk categories (aOR, 2.44; 95% CI, 0.40-14.83; aOR, 1.69; 95% CI, 0.75-3.85; and aOR, 2.10; 95% CI, 0.59-7.54 for the lowest, moderate, and highest risk categories, respectively; interaction <i>p</i> = 0.32). Using a clustering approach, point estimates for HFOV were also consistent (cluster 1: aOR, 1.85; 95% CI, 1.15-3.00 and cluster 2: aOR, 1.75; 95% CI, 0.91-3.38; interaction <i>p</i> = 0.75).</p><p><strong>Conclusions: </strong>We did not identify heterogeneity in the effect of HFOV across different subgroups of patients with ARDS.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"6 11","pages":"e1178"},"PeriodicalIF":0.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11548902/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142633862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mindfulness Exercises Reduce Acute Physiologic Stress Among Female Clinicians. 正念练习能减轻女临床医生的急性生理压力。
Q4 Medicine Pub Date : 2024-10-25 eCollection Date: 2024-11-01 DOI: 10.1097/CCE.0000000000001171
Amy H J Wolfe, Pamela S Hinds, Adre J du Plessis, Heather Gordish-Dressman, Vicki Freedenberg, Lamia Soghier

Importance: Approximately 50% of clinicians experience excessive emotional, physical, and mental stress, with repercussions across the entire medical system. Mindfulness exercises may mitigate this excessive stress. Heart rate variability (HRV) is an objective stress measure that can quantify which mindfulness exercises provide the greatest stress reduction.

Objectives: To define the impact of specific mindfulness exercises on HRV, a surrogate for physiologic stress, and the relationship between physiologic (HRV) and subjective stress measured by the State-Trait Anxiety Inventory during a one-day mindfulness workshop.

Design, setting, and participants: This was a prospective observational pilot study performed at a quaternary children's hospital with diverse subspecialists of pediatric nurses, nurse practitioners, and physicians.

Main outcomes and measures: Our primary outcome measure was change in HRV from baseline during three mindfulness exercises.

Results: The grounding, deep breathing, and body scan exercises all produced statistically significant changes in HRV among our 13 female participants. The body scan exercise produced statistically significant changes in all studied HRV parameters compared with baseline. We observed significant increases in Root Mean Square of Successive Differences between normal heartbeats (p = 0.026), high frequency (p ≤ 0.001), and the parasympathetic nervous system index (p ≤ 0.001) reflecting increased parasympathetic tone (e.g., relaxation), whereas sd 2/sd 1 ratio (p ≤ 0.001) and the stress index (p = 0.004) were decreased reflecting sympathetic withdrawal (e.g., decreased stress). Subjective stress decreased after 1-day mindfulness training (44.6 to 27.2) (p < 0.001). Individuals with the largest decrease in subjective stress also had the most improvement in HRV during the body scan exercise.

Conclusions: Clinician stress levels (HRV) improved after participating in grounding, deep breathing, and body scan meditations, which may highlight their importance as stress reduction tools for clinicians. Monitoring of HRV during mindfulness exercises may provide deeper understanding of which specific exercises produce the greatest physiologic stress reduction for individual participants and the trend of these changes over time.

重要性:约有 50% 的临床医生会承受过大的情绪、身体和精神压力,并对整个医疗系统产生影响。正念练习可以减轻这种过度的压力。心率变异性(HRV)是一种客观的压力测量方法,可以量化哪些正念练习能最大程度地减轻压力:明确特定正念练习对心率变异(生理压力的替代物)的影响,以及在为期一天的正念工作坊期间,生理压力(心率变异)与状态-特质焦虑量表测量的主观压力之间的关系:这是一项前瞻性观察试验研究,在一家由儿科护士、执业护士和医生等不同专业人员组成的四级儿童医院进行:我们的主要结果指标是三种正念练习期间心率变异从基线到基线的变化:在 13 名女性参与者中,接地、深呼吸和身体扫描练习都对心率变异产生了统计学意义上的显著变化。与基线相比,身体扫描练习使所有研究的心率变异参数都发生了统计学意义上的显著变化。我们观察到,正常心跳间连续差值的均方根(p = 0.026)、高频率(p ≤ 0.001)和副交感神经系统指数(p ≤ 0.001)均有明显增加,反映出副交感神经张力增强(如放松),而 sd 2/sd 1 比率(p ≤ 0.001)和压力指数(p = 0.004)则有所下降,反映出交感神经功能减退(如压力减小)。为期一天的正念训练后,主观压力有所下降(从 44.6 降至 27.2)(p < 0.001)。主观压力下降幅度最大的人在身体扫描练习中心率变异的改善幅度也最大:临床医生在参加接地、深呼吸和身体扫描冥想后,压力水平(心率变异)得到改善,这可能凸显了它们作为临床医生减压工具的重要性。在正念练习过程中监测心率变异可能会让人更深入地了解哪些特定练习能最大程度地减轻参与者的生理压力,以及这些变化随时间推移的趋势。
{"title":"Mindfulness Exercises Reduce Acute Physiologic Stress Among Female Clinicians.","authors":"Amy H J Wolfe, Pamela S Hinds, Adre J du Plessis, Heather Gordish-Dressman, Vicki Freedenberg, Lamia Soghier","doi":"10.1097/CCE.0000000000001171","DOIUrl":"10.1097/CCE.0000000000001171","url":null,"abstract":"<p><strong>Importance: </strong>Approximately 50% of clinicians experience excessive emotional, physical, and mental stress, with repercussions across the entire medical system. Mindfulness exercises may mitigate this excessive stress. Heart rate variability (HRV) is an objective stress measure that can quantify which mindfulness exercises provide the greatest stress reduction.</p><p><strong>Objectives: </strong>To define the impact of specific mindfulness exercises on HRV, a surrogate for physiologic stress, and the relationship between physiologic (HRV) and subjective stress measured by the State-Trait Anxiety Inventory during a one-day mindfulness workshop.</p><p><strong>Design, setting, and participants: </strong>This was a prospective observational pilot study performed at a quaternary children's hospital with diverse subspecialists of pediatric nurses, nurse practitioners, and physicians.</p><p><strong>Main outcomes and measures: </strong>Our primary outcome measure was change in HRV from baseline during three mindfulness exercises.</p><p><strong>Results: </strong>The grounding, deep breathing, and body scan exercises all produced statistically significant changes in HRV among our 13 female participants. The body scan exercise produced statistically significant changes in all studied HRV parameters compared with baseline. We observed significant increases in Root Mean Square of Successive Differences between normal heartbeats (p = 0.026), high frequency (p ≤ 0.001), and the parasympathetic nervous system index (p ≤ 0.001) reflecting increased parasympathetic tone (e.g., relaxation), whereas sd 2/sd 1 ratio (p ≤ 0.001) and the stress index (p = 0.004) were decreased reflecting sympathetic withdrawal (e.g., decreased stress). Subjective stress decreased after 1-day mindfulness training (44.6 to 27.2) (p < 0.001). Individuals with the largest decrease in subjective stress also had the most improvement in HRV during the body scan exercise.</p><p><strong>Conclusions: </strong>Clinician stress levels (HRV) improved after participating in grounding, deep breathing, and body scan meditations, which may highlight their importance as stress reduction tools for clinicians. Monitoring of HRV during mindfulness exercises may provide deeper understanding of which specific exercises produce the greatest physiologic stress reduction for individual participants and the trend of these changes over time.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"6 11","pages":"e1171"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Travel Distances for Interhospital Transfers of Critically Ill Children: A Geospatial Analysis. 重症儿童院间转运的旅行距离:地理空间分析
Q4 Medicine Pub Date : 2024-10-25 eCollection Date: 2024-11-01 DOI: 10.1097/CCE.0000000000001175
Allan M Joseph, Christopher M Horvat, Billie S Davis, Jeremy M Kahn

Importance: The U.S. pediatric acute care system has become more centralized, placing increasing importance on interhospital transfers.

Objectives: We conducted a geospatial analysis of critically ill children undergoing interfacility transfer with a specific focus on understanding travel distances between the patient's residence and the hospitals in which they receive care.

Design, setting, and participants: Retrospective geospatial analysis using five U.S. state-level administrative databases; four states observed from 2016 to 2019 and one state from 2018 to 2019. Participants included 10,665 children who experienced 11,713 episodes of critical illness involving transfer between two hospitals.

Main outcomes and measures: Travel distances and the incidence of "potentially suboptimal triage," in which patients were transferred to a second hospital less than five miles further from their residence than the first hospital.

Results: Patients typically present to hospitals near their residence (median distance from residence to first hospital, 4.2 miles; interquartile range [IQR], 1.8-9.6 miles). Transfer distances are relatively large (median distance between hospitals, 28.9 miles; IQR, 11.2-53.2 miles), taking patients relatively far away from their residences (median distance from residence to second hospital, 30.1 miles; IQR, 12.2-54.9 miles). Potentially suboptimal triage was frequent: 24.2 percent of patients were transferred to a hospital less than five miles further away from their residence than the first hospital. Potentially suboptimal triage was most common in children living in urban counties, and became less common with increasing medical complexity.

Conclusions and relevance: The current pediatric critical care system is organized in a hub-and-spoke model, which requires large travel distances for some patients. Some transfers might be prevented by more efficient prehospital triage. Current transfer patterns suggest the choice of initial hospital is influenced by geography as well as by attempts to match hospital resources with perceived patient needs.

重要性:美国儿科急症护理系统变得越来越集中,医院间转院也变得越来越重要:我们对接受医院间转院的重症患儿进行了地理空间分析,重点了解患者居住地与接受治疗的医院之间的距离:使用五个美国州级行政数据库进行回顾性地理空间分析;其中四个州的观察期为 2016 年至 2019 年,一个州的观察期为 2018 年至 2019 年。参与者包括 10,665 名儿童,他们经历了 11,713 次危重病发作,涉及在两家医院之间转院:旅行距离和 "潜在次优分流 "的发生率,即患者被转到距离其居住地比第一家医院远不到五英里的第二家医院:结果:患者通常会到居住地附近的医院就诊(从居住地到第一家医院的距离中位数为 4.2 英里;四分位数间距 [IQR],1.8-9.6 英里)。转院距离相对较远(医院之间的中位距离为 28.9 英里;IQR 为 11.2-53.2 英里),患者距离住所相对较远(从住所到第二家医院的中位距离为 30.1 英里;IQR 为 12.2-54.9 英里)。潜在的次优分流很常见:24.2%的患者被转到了距离其住所比第一家医院远不到五英里的医院。潜在的次优分流在居住在城市县城的儿童中最为常见,随着医疗复杂程度的增加,这种情况越来越少:目前的儿科重症监护系统采用的是 "枢纽-辐射 "模式,这就要求一些患者必须长途跋涉。更有效的院前分诊可以避免一些转院。目前的转院模式表明,初始医院的选择受到地理位置以及医院资源与患者需求相匹配的影响。
{"title":"Travel Distances for Interhospital Transfers of Critically Ill Children: A Geospatial Analysis.","authors":"Allan M Joseph, Christopher M Horvat, Billie S Davis, Jeremy M Kahn","doi":"10.1097/CCE.0000000000001175","DOIUrl":"10.1097/CCE.0000000000001175","url":null,"abstract":"<p><strong>Importance: </strong>The U.S. pediatric acute care system has become more centralized, placing increasing importance on interhospital transfers.</p><p><strong>Objectives: </strong>We conducted a geospatial analysis of critically ill children undergoing interfacility transfer with a specific focus on understanding travel distances between the patient's residence and the hospitals in which they receive care.</p><p><strong>Design, setting, and participants: </strong>Retrospective geospatial analysis using five U.S. state-level administrative databases; four states observed from 2016 to 2019 and one state from 2018 to 2019. Participants included 10,665 children who experienced 11,713 episodes of critical illness involving transfer between two hospitals.</p><p><strong>Main outcomes and measures: </strong>Travel distances and the incidence of \"potentially suboptimal triage,\" in which patients were transferred to a second hospital less than five miles further from their residence than the first hospital.</p><p><strong>Results: </strong>Patients typically present to hospitals near their residence (median distance from residence to first hospital, 4.2 miles; interquartile range [IQR], 1.8-9.6 miles). Transfer distances are relatively large (median distance between hospitals, 28.9 miles; IQR, 11.2-53.2 miles), taking patients relatively far away from their residences (median distance from residence to second hospital, 30.1 miles; IQR, 12.2-54.9 miles). Potentially suboptimal triage was frequent: 24.2 percent of patients were transferred to a hospital less than five miles further away from their residence than the first hospital. Potentially suboptimal triage was most common in children living in urban counties, and became less common with increasing medical complexity.</p><p><strong>Conclusions and relevance: </strong>The current pediatric critical care system is organized in a hub-and-spoke model, which requires large travel distances for some patients. Some transfers might be prevented by more efficient prehospital triage. Current transfer patterns suggest the choice of initial hospital is influenced by geography as well as by attempts to match hospital resources with perceived patient needs.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"6 11","pages":"e1175"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519404/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Increased Opioid Use During Postoperative Intensive Care. 术后重症监护期间阿片类药物使用增加的风险因素。
Q4 Medicine Pub Date : 2024-10-25 eCollection Date: 2024-11-01 DOI: 10.1097/CCE.0000000000001172
Lauriane Guichard, Milo C Engoren, Yi-Ju Li, Matthew J Sigakis, Xinming An, Chad M Brummett, Matthew C Mauck, Karthik Raghunathan, Daniel J Clauw, Vijay Krishnamoorthy

Importance: In the ICU, opioids treat pain and improve ventilator tolerance as part of an analgosedation approach. Identifying predictors of opioid consumption during the ICU course might highlight actionable items to reduce opioid consumption.

Objectives: To identify risk factors for opioid use during a postoperative ICU course.

Design, setting, and participants: Patients enrolled in the Michigan Genomics Initiative single-center prospective observational cohort study completed baseline preoperative sociodemographic and mental/physical health questionnaires and provided blood samples for genetic analysis. Included patients were 18 years old and older, admitted to ICU postoperatively, and received opioids postoperatively.

Main outcomes and measures: The primary outcome was ICU mean daily oral morphine equivalent (OME) use. The association between OME and phenotypic risk factors and genetic variants previously associated with pain were analyzed through univariable and multivariable linear regression models.

Results: The cohort consisted of 1865 mixed-surgical patients with mean age of 56 years (sd, 15 yr). Preoperative opioid users were more likely to continue to receive opioids throughout their ICU stay than opioid-naive patients. OME (log10 scale) was most strongly associated with ICU mechanical ventilation (β = 0.27; 95% CI, 0.15-0.38; p < 0.0001; effect size 1.85 for receiving > 24 hours of mechanical ventilation), preoperative opioid use (β = 0.22; 95% CI, 0.16-0.29; p < 0.0001; effect size 1.67 for receiving preoperative opioids), major surgery (β = 0.21; 95% CI, 0.12-0.30; p < 0.0001; effect size 1.62 compared with minor surgery), and current/former illicit drug use (β = 0.12; 95% CI, 0.01-0.23; p = 0.04; effect size 1.30 for drug use). Younger age, centralized pain, and longer anesthetic duration were also significantly associated with OME but with smaller effect sizes. Selected genetic variants (FKBP5, COMT, and OPRM1) were not associated with OME use.

Conclusions and relevance: Mechanical ventilation and preoperative opioids were the strongest risk factors for postoperative ICU opioid consumption, whereas psychologic factors and genetic variants were not associated.

重要性:在重症监护室,阿片类药物可治疗疼痛并改善呼吸机耐受性,是镇痛方法的一部分。确定重症监护室病程中阿片类药物消耗的预测因素可突出减少阿片类药物消耗的可行项目:确定术后重症监护室病程中阿片类药物使用的风险因素:密歇根基因组学倡议"(Michigan Genomics Initiative)单中心前瞻性观察队列研究的入组患者填写了术前社会人口学和心理/生理健康基线问卷,并提供了用于基因分析的血液样本。纳入研究的患者年龄在 18 岁及以上,术后入住 ICU,术后接受阿片类药物治疗:主要结果和测量指标:主要结果是重症监护室平均每日口服吗啡当量(OME)的使用量。通过单变量和多变量线性回归模型分析了OME与表型风险因素以及之前与疼痛相关的基因变异之间的关系:队列由 1865 名混合手术患者组成,平均年龄为 56 岁(sd,15 岁)。与未使用阿片类药物的患者相比,术前使用阿片类药物的患者更有可能在整个重症监护室住院期间继续接受阿片类药物治疗。OME(log10标度)与ICU机械通气(β = 0.27; 95% CI, 0.15-0.38; p < 0.0001; 接受> 24小时机械通气的效应大小为1.85)、术前阿片类药物使用(β = 0.22; 95% CI, 0.16-0.29; p < 0.0001;术前接受阿片类药物的效应大小为 1.67)、大手术(β = 0.21;95% CI,0.12-0.30;p < 0.0001;与小手术相比,效应大小为 1.62)以及当前/曾经使用非法药物(β = 0.12;95% CI,0.01-0.23;p = 0.04;使用药物的效应大小为 1.30)。年龄较小、疼痛集中和麻醉时间较长也与 OME 显著相关,但效应大小较小。某些基因变异(FKBP5、COMT 和 OPRM1)与 OME 的使用无关:机械通气和术前阿片类药物是 ICU 术后阿片类药物消耗的最大风险因素,而心理因素和基因变异则与之无关。
{"title":"Risk Factors for Increased Opioid Use During Postoperative Intensive Care.","authors":"Lauriane Guichard, Milo C Engoren, Yi-Ju Li, Matthew J Sigakis, Xinming An, Chad M Brummett, Matthew C Mauck, Karthik Raghunathan, Daniel J Clauw, Vijay Krishnamoorthy","doi":"10.1097/CCE.0000000000001172","DOIUrl":"10.1097/CCE.0000000000001172","url":null,"abstract":"<p><strong>Importance: </strong>In the ICU, opioids treat pain and improve ventilator tolerance as part of an analgosedation approach. Identifying predictors of opioid consumption during the ICU course might highlight actionable items to reduce opioid consumption.</p><p><strong>Objectives: </strong>To identify risk factors for opioid use during a postoperative ICU course.</p><p><strong>Design, setting, and participants: </strong>Patients enrolled in the Michigan Genomics Initiative single-center prospective observational cohort study completed baseline preoperative sociodemographic and mental/physical health questionnaires and provided blood samples for genetic analysis. Included patients were 18 years old and older, admitted to ICU postoperatively, and received opioids postoperatively.</p><p><strong>Main outcomes and measures: </strong>The primary outcome was ICU mean daily oral morphine equivalent (OME) use. The association between OME and phenotypic risk factors and genetic variants previously associated with pain were analyzed through univariable and multivariable linear regression models.</p><p><strong>Results: </strong>The cohort consisted of 1865 mixed-surgical patients with mean age of 56 years (sd, 15 yr). Preoperative opioid users were more likely to continue to receive opioids throughout their ICU stay than opioid-naive patients. OME (log10 scale) was most strongly associated with ICU mechanical ventilation (β = 0.27; 95% CI, 0.15-0.38; p < 0.0001; effect size 1.85 for receiving > 24 hours of mechanical ventilation), preoperative opioid use (β = 0.22; 95% CI, 0.16-0.29; p < 0.0001; effect size 1.67 for receiving preoperative opioids), major surgery (β = 0.21; 95% CI, 0.12-0.30; p < 0.0001; effect size 1.62 compared with minor surgery), and current/former illicit drug use (β = 0.12; 95% CI, 0.01-0.23; p = 0.04; effect size 1.30 for drug use). Younger age, centralized pain, and longer anesthetic duration were also significantly associated with OME but with smaller effect sizes. Selected genetic variants (FKBP5, COMT, and OPRM1) were not associated with OME use.</p><p><strong>Conclusions and relevance: </strong>Mechanical ventilation and preoperative opioids were the strongest risk factors for postoperative ICU opioid consumption, whereas psychologic factors and genetic variants were not associated.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"6 11","pages":"e1172"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519407/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Continuous and Noninvasive Method to Estimate Pao2/Fio2 Ratio. 估算 Pao2/Fio2 比率的连续无创方法
Q4 Medicine Pub Date : 2024-10-25 eCollection Date: 2024-11-01 DOI: 10.1097/CCE.0000000000001174
Francis-Olivier Beauchamp, Michaël Sauthier

Objectives: To validate a method for continuously estimating the Pao2/Fio2 (PF) ratio in all critically ill pediatric patients using only standard continuous data monitoring.

Design: Retrospective study on a high temporal resolution database.

Setting: PICU in Montreal, QC, Canada.

Patients/subjects: We included any patients admitted from May 2015 to May 2023 who had an arterial blood gas (ABG) with concurrent continuous pulsed oximetry saturation (Spo2) values. We used our previously validated mathematical model to determine the magnitude of hypoxemia by computing the estimated ePao2/Fio2 (ePF) ratio and comparing it to the Spo2/Fio2 (SF), using PF ratio as the reference standard.

Interventions: None.

Measurements and main results: We analyzed a total of 20,828 ABGs. When Spo2 was below or equal to 97%, the ePF ratio showed a significantly better hypoxemia classification (none, light/moderate, or severe) than the SF ratio (0.80 vs. 0.72; p < 0.001), a lower fixed bias (16.26 vs. -35.24; p < 0.001), a lower mean absolute error (37.92 vs. 63.93; p < 0.001) and a lower proportional bias (slope of 1.01 vs. 0.81; p < 0.001). ePF ratio has also a better limits of agreement difference from Bland-Altman plot (248.10 vs. 292.45; p < 0.001) and coefficient of determination (0.68 vs. 0.59; p < 0.001). When Spo2 was above 97%, the ePF ratio had better classification with Kappa (0.53 vs. 0.43; p < 0.001) and lower fixed bias (-0.63 vs. 65.68; p < 0.001).

Conclusions: The PF ratio based on ePF allows for a continuous estimation of hypoxemia severity with a better performance than the SF ratio.

目的验证一种仅使用标准连续数据监测对所有重症儿科患者的 Pao2/Fio2 (PF) 比率进行连续估算的方法:设计:对高时间分辨率数据库进行回顾性研究:患者/受试者:我们纳入了从 2015 年 5 月至 2023 年 5 月期间入院的所有患者,这些患者均有动脉血气 (ABG) 和同期连续脉冲血氧饱和度 (Spo2) 值。我们使用之前验证过的数学模型,通过计算估计的 ePao2/Fio2 (ePF) 比值来确定低氧血症的程度,并将其与 Spo2/Fio2 (SF) 进行比较,以 PF 比值作为参考标准:干预措施:无:我们共分析了 20,828 份 ABG。当 Spo2 低于或等于 97% 时,ePF 比值显示的低氧血症分类(无、轻度/中度或重度)明显优于 SF 比值(0.80 vs. 0.72;p <0.001),固定偏差更低(16.26 vs. -35.24;p <0.001),平均绝对误差更低(37.从布兰德-阿尔特曼图(248.10 vs. 292.45; p < 0.001)和决定系数(0.68 vs. 0.59; p < 0.001)来看,ePF 比值也具有更好的一致性差异(248.10 vs. 292.45; p < 0.001)和决定系数(0.68 vs. 0.59; p < 0.001)。当 Spo2 超过 97% 时,ePF 比率的分类效果更好,Kappa 值(0.53 vs. 0.43;p < 0.001)和固定偏差(-0.63 vs. 65.68;p < 0.001)更低:结论:基于 ePF 的 PF 比值可连续估计低氧血症的严重程度,其性能优于 SF 比值。
{"title":"A Continuous and Noninvasive Method to Estimate Pao<sub>2</sub>/Fio<sub>2</sub> Ratio.","authors":"Francis-Olivier Beauchamp, Michaël Sauthier","doi":"10.1097/CCE.0000000000001174","DOIUrl":"10.1097/CCE.0000000000001174","url":null,"abstract":"<p><strong>Objectives: </strong>To validate a method for continuously estimating the Pao<sub>2</sub>/Fio<sub>2</sub> (PF) ratio in all critically ill pediatric patients using only standard continuous data monitoring.</p><p><strong>Design: </strong>Retrospective study on a high temporal resolution database.</p><p><strong>Setting: </strong>PICU in Montreal, QC, Canada.</p><p><strong>Patients/subjects: </strong>We included any patients admitted from May 2015 to May 2023 who had an arterial blood gas (ABG) with concurrent continuous pulsed oximetry saturation (Spo<sub>2</sub>) values. We used our previously validated mathematical model to determine the magnitude of hypoxemia by computing the estimated ePao<sub>2</sub>/Fio<sub>2</sub> (ePF) ratio and comparing it to the Spo<sub>2</sub>/Fio<sub>2</sub> (SF), using PF ratio as the reference standard.</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>We analyzed a total of 20,828 ABGs. When Spo<sub>2</sub> was below or equal to 97%, the ePF ratio showed a significantly better hypoxemia classification (none, light/moderate, or severe) than the SF ratio (0.80 vs. 0.72; <i>p</i> < 0.001), a lower fixed bias (16.26 vs. -35.24; <i>p</i> < 0.001), a lower mean absolute error (37.92 vs. 63.93; <i>p</i> < 0.001) and a lower proportional bias (slope of 1.01 vs. 0.81; <i>p</i> < 0.001). ePF ratio has also a better limits of agreement difference from Bland-Altman plot (248.10 vs. 292.45; <i>p</i> < 0.001) and coefficient of determination (0.68 vs. 0.59; <i>p</i> < 0.001). When Spo<sub>2</sub> was above 97%, the ePF ratio had better classification with Kappa (0.53 vs. 0.43; <i>p</i> < 0.001) and lower fixed bias (-0.63 vs. 65.68; <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>The PF ratio based on ePF allows for a continuous estimation of hypoxemia severity with a better performance than the SF ratio.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"6 11","pages":"e1174"},"PeriodicalIF":0.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519398/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations Between Clinical Factors and Postoperative Thrombosis in Pediatric Cardiac Surgery Patients: A Single-Center Retrospective Study. 小儿心脏手术患者的临床因素与术后血栓形成之间的关系:单中心回顾性研究
Q4 Medicine Pub Date : 2024-10-21 eCollection Date: 2024-10-01 DOI: 10.1097/CCE.0000000000001170
Sven Chlench, Noa J Freudenthal

Importance: Postoperative thrombosis is a significant complication in pediatric cardiac surgery patients, contributing to morbidity and mortality. Identifying clinical factors associated with thrombosis can improve patient outcomes by guiding early detection and intervention.

Objectives: This study aimed to assess factors associated with postoperative thrombosis or thromboembolism in pediatric patients under 12 months old who underwent surgery for congenital heart disease (CHD). Design, Setting, and Participants: This retrospective cohort study analyzed electronic medical records from pediatric patients admitted to the Pediatric Cardiovascular Intensive Care Unit (PCICU) at the German Paediatric Heart Center, Bonn, between March 1, 2020, and March 1, 2021. A total of 197 children under 12 months old who underwent cardiac surgery were included in the analysis.

Main outcomes and measures: Thrombosis was diagnosed postoperatively using imaging modalities such as ultrasound, echocardiography, and computed tomography. The primary outcome was the incidence of thrombosis and its association with clinical factors such as age, central venous catheter (CVC) duration, CRP levels, and D-dimer levels.

Results: Among 197 patients, the incidence of thrombosis was 8.63%, predominantly venous (70.6%). Initial associations were observed between thrombosis and younger age, lower body weight, higher hematocrit, cyanosis, longer central venous catheter (CVC) use, and elevated C-reactive protein (CRP) and d-dimer levels. Receiver operating characteristic analysis indicated a higher risk in patients with d-dimer levels above 5.47 mg/L. The stepwise multiregression analysis identified longer CVC duration in situ (β = 0.553; p < 0.001), higher CRP levels (β = 0.217; p = 0.022), and younger age at admission (β = -0.254; p = 0.006) as significant predictors of thrombosis. Decision tree analysis identified CVC use longer than 12.5 days and CRP levels above 118.01 mg/L as the most critical risk factors.

Conclusions and relevance: Postoperative thrombosis is a notable risk in pediatric CHD patients, particularly in neonates. Prolonged CVC use and elevated CRP levels are critical risk factors. Routine monitoring of D-dimer and CRP levels, along with timely sonographic screening, can aid early thrombosis detection and intervention. Further research is warranted to optimize thrombosis prevention strategies in this population.

重要性:术后血栓形成是小儿心脏手术患者的重要并发症,可导致发病率和死亡率。找出与血栓形成相关的临床因素,可以指导早期发现和干预,从而改善患者的预后:本研究旨在评估因先天性心脏病(CHD)而接受手术的 12 个月以下小儿患者术后血栓形成或血栓栓塞的相关因素。设计、地点和参与者:这项回顾性队列研究分析了2020年3月1日至2021年3月1日期间波恩德国儿科心脏中心儿科心血管重症监护室(PCICU)收治的儿科患者的电子病历。共有197名12个月以下接受心脏手术的儿童纳入分析:主要结果和测量方法:术后通过超声波、超声心动图和计算机断层扫描等成像方式诊断血栓形成。主要结果是血栓形成的发生率及其与年龄、中心静脉导管(CVC)持续时间、CRP水平和D-二聚体水平等临床因素的关系:在 197 名患者中,血栓形成的发生率为 8.63%,主要是静脉血栓(70.6%)。血栓形成与年龄较小、体重较轻、血细胞比容较高、发绀、中心静脉导管(CVC)使用时间较长、C反应蛋白(CRP)和二聚体水平升高之间存在初步关联。接收器操作特征分析表明,d-二聚体水平高于 5.47 mg/L 的患者风险更高。逐步多元回归分析发现,原位 CVC 持续时间较长 (β = 0.553; p < 0.001)、CRP 水平较高 (β = 0.217; p = 0.022) 和入院时年龄较小 (β = -0.254; p = 0.006) 是血栓形成的重要预测因素。决策树分析认为,CVC使用时间超过12.5天和CRP水平超过118.01 mg/L是最关键的风险因素:术后血栓形成是儿科心脏疾病患者,尤其是新生儿的一个显著风险。长期使用 CVC 和 CRP 水平升高是关键的风险因素。对 D-二聚体和 CRP 水平进行常规监测,并及时进行超声波筛查,有助于血栓的早期发现和干预。有必要开展进一步研究,以优化该人群的血栓预防策略。
{"title":"Associations Between Clinical Factors and Postoperative Thrombosis in Pediatric Cardiac Surgery Patients: A Single-Center Retrospective Study.","authors":"Sven Chlench, Noa J Freudenthal","doi":"10.1097/CCE.0000000000001170","DOIUrl":"https://doi.org/10.1097/CCE.0000000000001170","url":null,"abstract":"<p><strong>Importance: </strong>Postoperative thrombosis is a significant complication in pediatric cardiac surgery patients, contributing to morbidity and mortality. Identifying clinical factors associated with thrombosis can improve patient outcomes by guiding early detection and intervention.</p><p><strong>Objectives: </strong>This study aimed to assess factors associated with postoperative thrombosis or thromboembolism in pediatric patients under 12 months old who underwent surgery for congenital heart disease (CHD). Design, Setting, and Participants: This retrospective cohort study analyzed electronic medical records from pediatric patients admitted to the Pediatric Cardiovascular Intensive Care Unit (PCICU) at the German Paediatric Heart Center, Bonn, between March 1, 2020, and March 1, 2021. A total of 197 children under 12 months old who underwent cardiac surgery were included in the analysis.</p><p><strong>Main outcomes and measures: </strong>Thrombosis was diagnosed postoperatively using imaging modalities such as ultrasound, echocardiography, and computed tomography. The primary outcome was the incidence of thrombosis and its association with clinical factors such as age, central venous catheter (CVC) duration, CRP levels, and D-dimer levels.</p><p><strong>Results: </strong>Among 197 patients, the incidence of thrombosis was 8.63%, predominantly venous (70.6%). Initial associations were observed between thrombosis and younger age, lower body weight, higher hematocrit, cyanosis, longer central venous catheter (CVC) use, and elevated C-reactive protein (CRP) and d-dimer levels. Receiver operating characteristic analysis indicated a higher risk in patients with d-dimer levels above 5.47 mg/L. The stepwise multiregression analysis identified longer CVC duration in situ (β = 0.553; p < 0.001), higher CRP levels (β = 0.217; p = 0.022), and younger age at admission (β = -0.254; p = 0.006) as significant predictors of thrombosis. Decision tree analysis identified CVC use longer than 12.5 days and CRP levels above 118.01 mg/L as the most critical risk factors.</p><p><strong>Conclusions and relevance: </strong>Postoperative thrombosis is a notable risk in pediatric CHD patients, particularly in neonates. Prolonged CVC use and elevated CRP levels are critical risk factors. Routine monitoring of D-dimer and CRP levels, along with timely sonographic screening, can aid early thrombosis detection and intervention. Further research is warranted to optimize thrombosis prevention strategies in this population.</p>","PeriodicalId":93957,"journal":{"name":"Critical care explorations","volume":"6 10","pages":"e1170"},"PeriodicalIF":0.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11495689/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Critical care explorations
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1